Delivery Order SPE2DB24D2018-SPE2DB24FWSJ2

Award Date 4/25/24
Potential Completion Date 4/26/24
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order with a ceiling value of $3,564.00 for the supply of BRILINTA 90 MG TABLET 60S. The award was issued by the Defense Logistics Agency (DLA), a major procurement arm of the Department of Defense (DoD), and has an ultimate completion date of December 13, 2022. Amerisourcebergen, a prominent pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Brilinta 90 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,876.98, has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4557297095 BRILINTA 90 MG TABLET 60S. The $1,720.23 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on May 19, 2022, with a completion date of May 20, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,069.60 for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,564,450,935 units of BRILINTA 90 MG Tablets, a prescription cardiovascular medication, with a ceiling value of $6,596.35. The contract is a firm-fixed-price arrangement with a period of performance through May 1, 2024. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,572.60 firm fixed-price delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of July 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,337.56. The contract delivers Brilinta 90 mg tablets to support healthcare requirements, with an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical, as well as a $750,000 IDC with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,680.55 Firm Fixed Price Delivery Order is for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The award has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical is valued up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,560.46 in Firm Fixed Price delivery orders for BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 6, 2025. No set-aside designation was used. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB24FWSJ2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Brilinta 90 mg tablets for the Defense Logistics Agency (DLA). The award, valued at $1,129.24, is a firm-fixed price Delivery Order with an ultimate completion date of April 26, 2024. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/16/25, 12:14 PM